Healthcare Services Group HCSG Stock options excluded as their inclusion would be anti-dilutive (in shares)
Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies
Other financials
Where this comes from
Reported directly by Healthcare Services Group in its filing.
Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.
The official record: Healthcare Services Group’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Healthcare Services Group's stock options excluded as their inclusion would be anti-dilutive (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Healthcare Services Group's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Healthcare Services Group (HCSG) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 1.2M in Q1 2026.
- How has Healthcare Services Group's stock options excluded as their inclusion would be anti-dilutive (in shares) changed year-over-year?
- Healthcare Services Group's stock options excluded as their inclusion would be anti-dilutive (in shares) decreased by 64.9% year-over-year, from 3.5M to 1.2M.
- What is the long-term trend for Healthcare Services Group's stock options excluded as their inclusion would be anti-dilutive (in shares)?
- Over 4 years (2021 to 2025), Healthcare Services Group's stock options excluded as their inclusion would be anti-dilutive (in shares) has grown at a 10.6% compound annual growth rate (CAGR), from 7.3M to 11M.
- What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
- Quantifies the number of potential common shares, such as stock options or warrants, excluded from the diluted earnings per share calculation because their inclusion would increase earnings per share. This metric provides transparency into the potential future dilution of existing shareholders. It is used to assess the impact of equity-based compensation on share counts.